ICCT — Icoreconnect Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $1.27m
- $6.94m
- $7.99m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.98 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -66.24% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.09 | 1.01 | 2.12 | 4.96 | 7.99 | n/a | n/a | 99.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
iCoreConnect Inc. is a cloud-based software and technology company. The Company is focused on workflow productivity and customer profitability through its enterprise platform of applications and services. The Company markets secure Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software-as-a-service (SaaS) offering under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, and iCoreIT. The Company’s software is sold under annual recurring revenue subscriptions. The Company also offers managed services and managed software-as-a-service (MSaaS)/managed service provider (MSP) approach, which keeps computers and networks up and running while data is accessible and safeguarded. It provides a unified threat management solution to protect against viruses, malware, spam, phishing and ransomware attacks.
Directors
- Robert McDermott PRE (49)
- Archit Shah CFO
- Srini Vasan CTO (53)
- Robert DeSanti DRC
- Joey Guerra DRC (60)
- Paul Jackson DRC
- John Schneller DRC (50)
- J. Smith DRC (45)
- Jeffrey Stellinga DRC (47)
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- November 2nd, 1992
- Public Since
- April 26th, 2019
- No. of Shareholders
- 547
- No. of Employees
- 41
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 196,352,276
- Address
- 529 E. Crown Point Road, Suite 250, OCOEE, 34761
- Web
- https://www.icoreconnect.com/
- Phone
- +1 4075058934
- Auditors
- Marcum LLP
Upcoming Events for ICCT
Q3 2023 Icoreconnect Inc Earnings Release
Similar to ICCT
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
What is the Icoreconnect share price?
As of Today at 01:11 UTC, shares in Icoreconnect are trading at $0.16. This share price information is delayed by 15 minutes.
How has the Icoreconnect share price performed this year?
Shares in Icoreconnect last closed at $0.16 and the price had moved by +110.76% over the past 365 days. In terms of relative price strength the Icoreconnect share price has outperformed the S&P500 Index by +84.49% over the past year.
What are the analyst and broker recommendations for Icoreconnect?
The overall consensus recommendation for Icoreconnect is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Icoreconnect dividend yield?
Icoreconnect does not currently pay a dividend.
Does Icoreconnect pay a dividend?
Icoreconnect does not currently pay a dividend.
When does Icoreconnect next pay dividends?
Icoreconnect does not currently pay a dividend.
How do I buy Icoreconnect shares?
To buy shares in Icoreconnect you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Icoreconnect?
As of the previous close price of $0.16, shares in Icoreconnect had a market capitalisation of $29.47m.
Where are Icoreconnect shares listed?
Here are the trading details for Icoreconnect:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ICCT
What kind of share is Icoreconnect?
Based on an overall assessment of its quality, value and momentum Icoreconnect is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Icoreconnect share price forecast for 2023?
We could not find analyst target price data for this security.
What is the trend in the Icoreconnect share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Icoreconnect. Over the past six months, its share price has outperformed the S&P500 Index by +14.81%.
As of the last closing price of $0.16, shares in Icoreconnect were trading +31.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Icoreconnect PE Ratio?
The Icoreconnect PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Icoreconnect?
Icoreconnect's management team is headed by:
- Robert McDermott - PRE
- Archit Shah - CFO
- Srini Vasan - CTO
- Robert DeSanti - DRC
- Joey Guerra - DRC
- Paul Jackson - DRC
- John Schneller - DRC
- J. Smith - DRC
- Jeffrey Stellinga - DRC